Genedrive PLC
LSE:GDR
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
UK |
G
|
Genedrive PLC
LSE:GDR
|
3.6m GBP | -0.7 | |
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
228.4B USD | 38.1 | ||
US |
Danaher Corp
NYSE:DHR
|
186.3B USD | 23.1 | ||
US |
Agilent Technologies Inc
NYSE:A
|
43.3B USD | 35 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.6B USD | 30.6 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.2B CHF | 56.9 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 64.8 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
31.2B USD | 40.1 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.1B USD | 46 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
25.6B USD | 37.5 | ||
US |
Waters Corp
NYSE:WAT
|
20.7B USD | 34.3 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.